Difference between revisions of "Part:BBa K4147008"

Line 13: Line 13:
  
 
===Characterization of PelB-(CBD)2-DrsB1 Construct with DsbA ===
 
===Characterization of PelB-(CBD)2-DrsB1 Construct with DsbA ===
[[File:PelB-(CBD)2-DrsB1_Construct_with_DsbA_Map.png |300px|thumb|center|alt=domestication.|<center><b>Figure 1</b>. SnapGene®️ map of BioBrick BBa_K4147008.</center>]]
+
<center>[[File:PelB-(CBD)2-DrsB1_Construct_with_DsbA_Map.png |300px]]</center>
 +
<center><b>Figure 1</b>. SnapGene®️ map of BioBrick BBa_K4147008.</center>
 
===REFERENCES===
 
===REFERENCES===
 
[1] Zhang QY, Yan ZB, Meng YM, et al. Antimicrobial peptides: mechanism of action, activity and clinical potential. Mil Med Res. 2021;8(1):48. Published 2021 Sep 9. doi:10.1186/s40779-021-00343-2
 
[1] Zhang QY, Yan ZB, Meng YM, et al. Antimicrobial peptides: mechanism of action, activity and clinical potential. Mil Med Res. 2021;8(1):48. Published 2021 Sep 9. doi:10.1186/s40779-021-00343-2

Revision as of 20:34, 9 October 2022


PelB-(CBD)2-DrsB1 Construct with DsbA

This part contains the (CBD)2-DrsB1 expression construct (BBa_K4147001) with co-expression of DsbA (BBa_K4147006) for disulfide bond formation and proper folding of the osmotin protein.

Usage and Biology

The disulfide bonds are essential for structure stabilization and biological functions of these peptides [1].

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal NgoMIV site found at 1184
    Illegal NgoMIV site found at 1368
    Illegal AgeI site found at 392
    Illegal AgeI site found at 671
  • 1000
    COMPATIBLE WITH RFC[1000]

Characterization of PelB-(CBD)2-DrsB1 Construct with DsbA

PelB-(CBD)2-DrsB1 Construct with DsbA Map.png
Figure 1. SnapGene®️ map of BioBrick BBa_K4147008.

REFERENCES

[1] Zhang QY, Yan ZB, Meng YM, et al. Antimicrobial peptides: mechanism of action, activity and clinical potential. Mil Med Res. 2021;8(1):48. Published 2021 Sep 9. doi:10.1186/s40779-021-00343-2